RAPGEF3 and prostate cancer: Epac may promote the proliferation and migration of prostate cancer cells through B-Raf/ERK and mTOR signaling cascades (Misra and Pizzo, 2009) or Ras/MAPK signaling (Misra and Pizzo, 2013).